The trial failed an interim evaluation. So no further patients will be recruited, but the existing patients will be followed up and trial results evaluated. But obviously it's bad news.
KZA Price at posting:
29.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
